Literature DB >> 449700

Mineralocorticoid-induced blood pressure, electrolyte, and hormone changes, and reversal with spironolactone, in healthy men.

M G Nicholls, L E Ramsay, K Boddy, R Fraser, J J Morton, J I Robertson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 449700     DOI： 10.1016/0026-0495(79)90201-4

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  4 in total

1.  Effect of fludrocortisone and spironolactone on sodium and potassium losses in secretory diarrhea.

Authors:  H H Wenzl; K D Fine; C A Santa Ana; J L Porter; J S Fordtran
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

2.  Assessment of the antimineralocorticoid effect of RU 28318 in healthy men with induced exogenous and endogenous hypermineralocorticism.

Authors:  A Ulmann; C Bertagna; A Le Go; J M Husson; A Tache; P Sassano; J Menard; P Corvol
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Extreme metabolic alkalosis with fludrocortisone therapy.

Authors:  A Burns; T M Brown; P Semple
Journal:  Postgrad Med J       Date:  1983-08       Impact factor: 2.401

4.  Incidental Congestive Heart Failure in Patients With Aldosterone-Producing Adenomas.

Authors:  Wei-Chieh Huang; Ying-Ying Chen; Yen-Hung Lin; Likwang Chen; Po-Chih Lin; Yu-Feng Lin; Yu-Chun Liu; Che-Hsiung Wu; Jeff S Chueh; Tzong-Shinn Chu; Kwan Dun Wu; Chun-Yao Huang; Vin-Cent Wu
Journal:  J Am Heart Assoc       Date:  2019-12-05       Impact factor: 5.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.